2015-2020年圆锥角膜管理趋势与社会人口学模式:美国眼科学会IRIS®登记分析
基于美国眼科学会IRIS®登记的回顾性队列研究,纳入2015-2020年新诊断圆锥角膜患者66 199例。角膜胶原交联(CXL)使用比例从2015年0.05%升至2020年29.5%,平均诊断年龄从44.1岁降至39.2岁。多变量分析显示年龄、性别、种族、民族、地区和保险状态与治疗方式相关。
要点
- CXL使用比例从2015年0.05%增至2020年29.5%(P=0.008)。
- 平均诊断年龄从2015年44.1岁降至2020年39.2岁(P<0.001)。
- 年龄增长与CXL几率降低相关,男性、黑人和西班牙裔患者治疗方式存在差异。
核心结论
- 2015年至2020年CXL使用显著增加。
- 圆锥角膜患者治疗的社会人口学差异可能反映获取、使用或诊疗模式的差异,未来研究应致力于确定改善所有患者可及性的策略。
研究设计与样本
- 回顾性队列研究,使用美国眼科学会IRIS®登记识别2015-2020年新诊断圆锥角膜患者,共66 199例。
- 采用多变量逻辑回归评估社会人口学因素与治疗方式的关联。
主要发现
- CXL使用比例从2015年0.05%上升至2020年29.5%(P=0.008)。
- 圆锥角膜患者平均年龄(标准差)从2015年44.1(±16.9)岁下降至2020年39.2(±16.9)岁(P<0.001)。
- 以0-20岁为参照,CXL vs 无手术的OR(95%CI)从21-40岁的0.62(0.57-0.67;P<0.0001)降至>60岁的0.03(0.02-0.04;P<0.0001)。
- 男性较女性更可能接受CXL(OR 1.31;95%CI 1.23-1.40;P<0.0001)和角膜移植(OR 1.30;95%CI 1.19-1.42;P<0.0001)。
- 黑人患者较白人患者接受CXL的可能性更低(OR 0.70;95%CI 0.63-0.77;P<0.0001),接受角膜移植的可能性更高(OR 2.24;95%CI 2.01-2.50;P<0.0001);西班牙裔患者较非西班牙裔患者CXL(OR 1.12;95%CI 1.00-1.24;P<0.05)和角膜移植(OR 1.29;95%CI 1.12-1.50;P<0.001)的几率更高。
关键数值与推荐
- CXL使用比例:2015年0.05% vs 2020年29.5%(P=0.008)。
- 平均诊断年龄:2015年44.1(±16.9)岁 vs 2020年39.2(±16.9)岁(P<0.001)。
- 年龄与CXL几率:以0-20岁为参照,21-40岁OR 0.62(95%CI 0.57-0.67;P<0.0001),>60岁OR 0.03(95%CI 0.02-0.04;P<0.0001)。
- 男性vs女性:CXL OR 1.31(95%CI 1.23-1.40;P<0.0001),角膜移植OR 1.30(95%CI 1.19-1.42;P<0.0001)。
- 黑人vs白人:CXL OR 0.70(95%CI 0.63-0.77;P<0.0001),角膜移植OR 2.24(95%CI 2.01-2.50;P<0.0001);西班牙裔vs非西班牙裔:CXL OR 1.12(95%CI 1.00-1.24;P<0.05),角膜移植OR 1.29(95%CI 1.12-1.50;P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Investigate trends in keratoconus (KCN) treatment patterns and diagnosis age from 2015 to 2020 and evaluate sociodemographic associations with the treatment approach. DESIGN: Retrospective cohort study. PARTICIPANTS: Patients with a new KCN diagnosis from 2015 to 2020 were identified in the Academy IRIS® Registry (Intelligent Research in Sight). METHODS: Associations between sociodemographic factors and treatment were evaluated using multivariable logistic regression. MAIN OUTCOME MEASURES: Outcomes included percentages and rates of each treatment (collagen crosslinking [CXL], keratoplasty, or no procedure) from 2015 to 2020, age at diagnosis during this period, and sociodemographic factors associated with treatment type. RESULTS: A total of 66 199 patients with a new diagnosis of KCN were identified. The percentage of patients undergoing CXL increased from 0.05% in 2015 to 29.5% in 2020 (P = 0.008). The average age (standard deviation) of KCN patients decreased from 44.1 (±16.9) years in 2015 to 39.2 (±16.9) years in 2020 (P < 0.001). In multivariable analyses comparing CXL versus no procedure and keratoplasty versus no procedure, patients undergoing CXL tended to be younger with the odds of having CXL decreasing with increasing age, for example, comparing CXL and no procedure patients, using ages 0-20 years as reference, the odds ratio (OR) (95% confidence interval [CI]) decreased from 0.62 (0.57-0.67; P < 0.0001) for patients aged 21-40 years to 0.03 (0.02-0.04; P < 0.0001) for patients aged > 60 years. Men were more likely than women to have CXL (OR, 1.31; 95% CI, 1.23-1.40; P < 0.0001) and keratoplasty (OR, 1.30; 95% CI, 1.19-1.42; P < 0.0001). Black patients were less likely than White patients to have CXL (OR, 0.70; 95% CI, 0.63-0.77; P < 0.0001) and more likely to have keratoplasty (OR, 2.24; 95% CI, 2.01-2.50; P < 0.0001). Likewise, Hispanic patients had higher odds of CXL (OR, 1.12; 95% CI, 1.00-1.24; P < 0.05) and keratoplasty (OR, 1.29; 95% CI, 1.12-1.50; P < 0.001) compared with non-Hispanic patients. Collagen crosslinking and keratoplasty also varied by region and insurance status. CONCLUSIONS: A significant increase in use of CXL was noted from 2015 to 2020. Sociodemographic differences in treatment among KCN patients may reflect differences in access, use, or care patterns, and future studies should aim to identify strategies to improve access for all patients. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
引用
- Syed ZA, Tomaiuolo M, Zhang Q, et al. Trends and Sociodemographic Patterns in Keratoconus Management 2015-2020: An American Academy of Ophthalmology IRIS® Registry Analysis. Ophthalmology. 2024. PMID: 38310973. doi:10.1016/j.ophtha.2024.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。